HAYWARD, Calif.--(BUSINESS WIRE)-- Aradigm Corporation (OTCBB:ARDM) (the “Company”) today announced that Igor Gonda, PhD., Aradigm’s President and CEO, will present at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 13, 2011 at 4:05 pm Eastern time. The conference is being held at the Waldorf=Astoria Hotel in New York.
A live webcast of the presentation will be available at www.aradigm.com and a webcast replay will be archived on the Company’s website for 60 days.
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation anthrax and tularemia infections and smoking cessation.
More information about Aradigm can be found at www.aradigm.com.
Except for the historical information contained herein, this news release contains forward-looking statements that involve risk and uncertainties, as well as the other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2010 filed with the SEC on March 25, 2011, and the Company’s Quarterly Reports on Form 10-Q.
Aradigm and the Aradigm Logo are registered trademarks of Aradigm Corporation.
Nancy Pecota, 510-265-8800
Chief Financial Officer
KEYWORDS: United States North America California New York
INDUSTRY KEYWORDS: Health Biotechnology Infectious Diseases Pharmaceutical